Implications for Public Health Regulation if Chevron Deference Is Overturned

Sahil Agrawal¹, Joseph S Ross^{2

3}, Reshma Ramachandran²

Affiliations

¹ Yale Law School, New Haven, Connecticut.
² Section of General Internal Medicine, Department of Internal Medicine, and Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, Connecticut.
³ Deputy Editor, JAMA.

Sahil Agrawal et al. JAMA. 2024.

. 2024 May 7;331(17):1443-1444.

doi: 10.1001/jama.2024.3654.

Sahil Agrawal¹, Joseph S Ross^{2

3}, Reshma Ramachandran²

¹ Yale Law School, New Haven, Connecticut.
² Section of General Internal Medicine, Department of Internal Medicine, and Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, Connecticut.
³ Deputy Editor, JAMA.

No abstract available

Plain language summary

This Viewpoint describes implications for medicine and public health if the US Supreme Court decides to overturn or narrow Chevron deference.